The 5 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 24.00, with a high estimate of 39.00 and a low estimate of 16.00. The median estimate represents a +69.73% increase from the last price of 14.14.
The current consensus among 5 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.42
Reporting Date Mar 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.